BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19850524)

  • 1. Ultraviolet radiation reduces resistance to Mycobacterium tuberculosis infection in BCG-vaccinated guinea pigs.
    Jeevan A; Sharma AK; McMurray DN
    Tuberculosis (Edinb); 2009 Nov; 89(6):431-8. PubMed ID: 19850524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.
    McMurray DN; Allen SS; Jeevan A; Lasco T; Cho H; Skwor T; Yamamoto T; McFarland C; Yoshimura T
    Tuberculosis (Edinb); 2005; 85(5-6):295-301. PubMed ID: 16253558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of interferon-gamma and tumour necrosis factor-alpha messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route.
    Jeevan A; Bonilla DL; McMurray DN
    Immunology; 2009 Sep; 128(1 Suppl):e296-305. PubMed ID: 19016908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
    Sugawara I; Udagawa T; Taniyama T
    Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal revaccination with Bacillus Calmette-Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice.
    Li W; Huang H; Hua W; Ben S; Liu H; Xu B; Xian Q; Tang Z; Shen H
    Vaccine; 2012 May; 30(21):3223-30. PubMed ID: 22342709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.
    Elias D; Akuffo H; Pawlowski A; Haile M; Schön T; Britton S
    Vaccine; 2005 Feb; 23(11):1326-34. PubMed ID: 15661380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.
    Goter-Robinson C; Derrick SC; Yang AL; Jeon BY; Morris SL
    Vaccine; 2006 Apr; 24(17):3522-9. PubMed ID: 16519971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vivo immunomodulatory effect of recombinant tumour necrosis factor-alpha in guinea pigs vaccinated with Mycobacterium bovis bacille Calmette-Guérin.
    Kramp JC; McMurray DN; Formichella C; Jeevan A
    Clin Exp Immunol; 2011 Jul; 165(1):110-20. PubMed ID: 21545584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung macrophages from bacille Calmette-Guérin-vaccinated guinea pigs suppress T cell proliferation but restrict intracellular growth of M. tuberculosis after recombinant guinea pig interferon-gamma activation.
    Jeevan A; Majorov K; Sawant K; Cho H; McMurray DN
    Clin Exp Immunol; 2007 Aug; 149(2):387-98. PubMed ID: 17565610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
    Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
    Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of alveolar and peritoneal macrophages from BCG-vaccinated guinea pigs.
    Cho H; de Haas R; Jeevan A; McMurray DN
    Tuberculosis (Edinb); 2008 Jul; 88(4):307-16. PubMed ID: 18165156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
    Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
    Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The immunological responses induced by Mycobacterium tuberculosis heat shock protein 16.3 and its synthetic peptide in mice].
    Shi CH; Zhang TF; Zhu DS; Zhang H; Bai B; Zhao Y; Yue CL; Zhao L; Liu JL
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug; 32(8):603-7. PubMed ID: 19958680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.